BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38702326)

  • 1. LncRNA IL21-AS1 facilitates tumour progression by enhancing CD24-induced phagocytosis inhibition and tumorigenesis in ovarian cancer.
    Liu J; Yan C; Xu S
    Cell Death Dis; 2024 May; 15(5):313. PubMed ID: 38702326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (
    Zhou Y; Li J; Yang X; Song Y; Li H
    Bioengineered; 2021 Dec; 12(2):12003-12022. PubMed ID: 34787052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HAND2-AS1 exerts anti-oncogenic effects on ovarian cancer via restoration of BCL2L11 as a sponge of microRNA-340-5p.
    Chen J; Lin Y; Jia Y; Xu T; Wu F; Jin Y
    J Cell Physiol; 2019 Dec; 234(12):23421-23436. PubMed ID: 31222748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis.
    Gu H; Lin R; Zheng F; Zhang Q
    J Mol Histol; 2021 Feb; 52(1):31-44. PubMed ID: 33099720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H; Zhou Y; Cheng H; Tian J; Yang S
    Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
    Chang H; Li B; Zhang X; Meng X
    Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA BBOX1-AS1 Aggravates the Development of Ovarian Cancer by Sequestering miR-361-3p to Augment PODXL Expression.
    Yao H; Chen R; Yang Y; Jiang J
    Reprod Sci; 2021 Mar; 28(3):736-744. PubMed ID: 33159291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6.
    Wang Y; Li L; Zhang X; Zhao X
    J Ovarian Res; 2022 Feb; 15(1):25. PubMed ID: 35168644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.
    Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L
    Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
    Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
    Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis.
    Ma Y; Zheng W
    J Ovarian Res; 2021 Jun; 14(1):76. PubMed ID: 34108034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H; Ding Y; Yang X
    Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway.
    Wang Y; Huang Y; Liu H; Su D; Luo F; Zhou F
    Biochem Biophys Res Commun; 2019 Jun; 514(1):44-50. PubMed ID: 31014670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
    Cao J; Wang H; Liu G; Tang R; Ding Y; Xu P; Wang H; Miao J; Gu X; Han S
    J Cell Mol Med; 2021 Jan; 25(2):1178-1189. PubMed ID: 33342041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
    Yin Z; Zhou Y; Ma T; Chen S; Shi N; Zou Y; Hou B; Zhang C
    J Cell Mol Med; 2020 May; 24(9):5028-5038. PubMed ID: 32301277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
    Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.